This review discusses the landscape of personalized prevention and management of obesity from a nutrigenetics perspective. Focusing on macronutrient tailoring, we discuss the impact of genetic variation on responses to carbohydrate, lipid, protein, and fiber consumption. Our bioinformatic analysis of genomic variants guiding macronutrient intake revealed enrichment of pathways associated with circadian rhythm, melatonin metabolism, cholesterol and lipoprotein remodeling and PPAR signaling as potential targets of macronutrients for the management of obesity in relevant genetic backgrounds. Notably, our data-based in silico predictions suggest the potential of repurposing the SYK inhibitor fostamatinib for obesity treatment in relevant genetic profiles. In addition to dietary considerations, we address genetic variations guiding lifestyle changes in weight management, including exercise and chrononutrition. Finally, we emphasize the need for a refined understanding and expanded research into the complex genetic landscape underlying obesity and its management.

The current consensus for the prevention and management of type 2 diabetes mellitus (T2DM) is that high-quality diets and adherence to a healthy lifestyle provide significant health benefits. Remarkably, however, there is little agreement on the proportions of macronutrients in the diet that should be recommended to people suffering from pre-diabetes or T2DM. We herein discuss emerging evidence that underscores the importance of gene-diet interactions in the improvement of glycemic biomarkers in T2DM. We propose that we can achieve better glycemic control in T2DM patients by coupling Mediterranean diets to genetic information as a predictor for optimal diet macronutrient composition in a personalized manner. We provide evidence to support this concept by presenting a case study of a T2DM patient who achieved rapid glycemic control when adhered to a personalized, genetically-guided Mediterranean Diet.

Type 2 diabetes mellitus (T2DM) is a heterogeneous metabolic disorder of multifactorial etiology that includes genetic and dietary influences. By addressing the latter, medical nutrition therapy (MNT) contributes to the management of T2DM or pre-diabetes toward achieving glycaemic control and improved insulin sensitivity. However, the clinical outcomes of MNT vary and may further benefit from personalized nutritional plans that take into consideration genetic variations associated with individual responses to macronutrients. The aim of the present series of n-of-1 trials was to assess the effects of genetically-guided vs. conventional MNT on patients with pre-diabetes or T2DM. A quasi-experimental, cross-over design was adopted in three Caucasian adult men with either diagnosis. Complete diet, bioclinical and anthropometric assessment was performed and a conventional MNT, based on the clinical practice guidelines was applied for 8 weeks. After a week of “wash-out,” a precision MNT was prescribed for an additional 8-week period, based on the genetic characteristics of each patient. Outcomes of interest included changes in body weight (BW), fasting plasma glucose (FPG), and blood pressure (BP). Collectively, the trials indicated improvements in BW, FPG, BP, and glycosylated hemoglobin (HbA1c) following the genetically-guided precision MNT intervention. Moreover, both patients with pre-diabetes experienced remission of the condition. We conclude that improved BW loss and glycemic control can be achieved in patients with pre-diabetes/T2DM, by coupling MNT to their genetic makeup, guiding optimal diet, macronutrient composition, exercise and oral nutrient supplementation in a personalized manner.

Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million adults by 2045. The current consensus for the prevention and management of type 2 diabetes (T2D) is that high-quality diets and adherence to a healthy lifestyle provide significant health benefits....

Background: Epidemiological studies on the effect of coffee intake on food consumption have yielded conflicting results. We sought to study the immediate and short-term effects of coffee consumption on food preferences, total calories, and macronutrient consumption within a specific, closely supervised experimental protocol. Methods: Twenty-one normal-weight volunteers completed this crossover, randomized, controlled study. Each volunteer took part in two trials consuming (a) 200 mL of instant coffee providing 5 mg of caffeine/kg body weight or (b) 200 mL of water (control). In both trials, participants were offered an ad libitum lunch meal from a buffet for 30 min. Proteins, lipids, and carbohydrates, as well as total caloric consumption were recorded during the initial 30 min period of the experiment (immediate period) as well as during the rest of the day (short-term period). Results: Coffee intake resulted in a statistically significant lower intake of immediate and short-term carbohydrate consumption (p = 0.012 and p = 0.047), of immediate protein consumption (p = 0.019), and of short-term lipid consumption (p = 0.04) versus water consumption. As a result, the calories consumed both immediately upon coffee administration and during the rest of the day of the experiment were significantly lower (p = 0.026 and p = 0.006) in the coffee group. Conclusions: Coffee intake seems to exert an anorexigenic result that last for several hours upon its consumption, particularly for carbohydrates and lipids.